Consumers may want to know where it was sourced, whether it was properly tested, or whether there is any meaningful recourse when they are harmed. Brunner predicts that if the FDA sends an affirmative signal to manufacturers, it will stimulate them to make the investment in CGMP compliance
FDA briefing document US Food and Drug Administration
In 2024, we also saw unprecedented willingness by large numbers of patients to pay out of pocket, even in European markets, as public coverage of AOMs is still limited, at best, and more often non-existent
123 (6 Pt 2), 17771788 (1993)
Predisposing factors to post-operative adhesion development
In- Clinic Blood Draws We offer blood draws for both Neighborhood Naturopathic and Primary Care and non-established/outside patients